Purilogics Overview

  • Founded
  • 2013
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $115K
Latest Deal Amount
  • Investors
  • 8

Purilogics General Information


Developer of disposable membrane chromatography columns designed to purify biologics for research and early stage drug trials. The company's columns are used for the downstream purification of a range of therapeutic agents that include monoclonal antibodies, recombinant and fusion proteins, enabling researchers to improve the speed of early stage development to get biologic to market faster where they are needed, to serve the large and growing population of patients with long-term, chronic conditions such as cancers, cardiovascular diseases and autoimmune disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Medical Supplies
Other Industries
Drug Discovery
Internet Retail
Other Devices and Supplies
Primary Office
  • ITOR 900B West Faris Road
  • Greenville, SC 29605
  • United States
+1 (864) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Purilogics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 30-Aug-2018 $115K Completed Generating Revenue
4. Grant 01-Jan-2017 00.000 Completed Generating Revenue
3. Grant 01-Jan-2016 00000 Completed Generating Revenue
2. Accelerator/Incubator 16-Apr-2015 Completed Startup
1. Grant $80K Completed Startup
To view Purilogics’s complete valuation and funding history, request access »

Purilogics Patents

Purilogics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3894428-A1 Affinity membrane and method of preparation Pending 12-Dec-2018 000000000000
US-20200188859-A1 Affinity membrane and method of preparation Pending 12-Dec-2018 000000000000
CA-3118156-A1 Affinity membrane and method of preparation Pending 12-Dec-2018 B01J20/28033

Purilogics Executive Team (2)

Name Title Board Seat Contact Info
Scott Husson Ph.D Co-Founder & President
Jinxiang Zhou Ph.D Co-Founder & Vice President
To view Purilogics’s complete executive team members history, request access »

Purilogics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Groupe Michelin Corporation 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
SCBIO Government 000 0000 000000 0
SC EPSCoR/IDeA Foundation Government 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »